Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Tanner

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|December 14, 2004
Levodopa and the progression of Parkinson's diseaseStanley Fahn, David Oakes, Ira Shoulson, et al.
Parkinsonism & Related Disorders|February 15, 2024
Racial disparities in hospitalization characteristics among Native Hawaiians, Pacific Islanders and Asian American subgroups with Parkinson's diseaseMichiko Kimura Bruno, Masako Matsunaga, Emma Krening, et al.
Scientific Data|February 26, 2020
Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson's diseaseLuba Smolensky, Ninad Amondikar, Karen Crawford, et al.
Annals of Neurology|July 12, 2002
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trialIra Shoulson, David Oakes, Stanley Fahn, et al.
Plos One|June 13, 2017
A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's diseaseBoris Hayete, Diane Wuest, Jason Laramie, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 9, 2023
Prevalence and Incidence of Parkinson's Disease in Latin America: A Meta-AnalysisDani J Kim, Ana L Isidro-Pérez, Michelle Doering, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's diseaseBernard Ravina, Kenneth Marek, Shirley Eberly, et al.
Journal of Parkinson'S Disease|August 28, 2019
Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change MeasuresLana M Chahine, Andrew Siderowf, Janel Barnes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 20, 2009
A longitudinal program for biomarker development in Parkinson's disease: a feasibility studyBernard Ravina, Caroline Tanner, Diane Dieuliis, et al.
NPJ Parkinson'S Disease|October 22, 2022
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortTanya Simuni, Kalpana Merchant, Michael C Brumm, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|December 14, 2004
Levodopa and the progression of Parkinson's diseaseStanley Fahn, David Oakes, Ira Shoulson, et al.
Parkinsonism & Related Disorders|February 15, 2024
Racial disparities in hospitalization characteristics among Native Hawaiians, Pacific Islanders and Asian American subgroups with Parkinson's diseaseMichiko Kimura Bruno, Masako Matsunaga, Emma Krening, et al.
Scientific Data|February 26, 2020
Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson's diseaseLuba Smolensky, Ninad Amondikar, Karen Crawford, et al.
Annals of Neurology|July 12, 2002
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trialIra Shoulson, David Oakes, Stanley Fahn, et al.
Plos One|June 13, 2017
A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's diseaseBoris Hayete, Diane Wuest, Jason Laramie, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 9, 2023
Prevalence and Incidence of Parkinson's Disease in Latin America: A Meta-AnalysisDani J Kim, Ana L Isidro-Pérez, Michelle Doering, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2012
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's diseaseBernard Ravina, Kenneth Marek, Shirley Eberly, et al.
Journal of Parkinson'S Disease|August 28, 2019
Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change MeasuresLana M Chahine, Andrew Siderowf, Janel Barnes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 20, 2009
A longitudinal program for biomarker development in Parkinson's disease: a feasibility studyBernard Ravina, Caroline Tanner, Diane Dieuliis, et al.
NPJ Parkinson'S Disease|October 22, 2022
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortTanya Simuni, Kalpana Merchant, Michael C Brumm, et al.
Pageof 6